ClinicalTrials.gov
public full text
Public Domain
Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)
This is a multicenter, international, single-arm, open-label, Phase 2 trial to evaluate the efficacy and safety of avelumab in participants with metastatic Merkel cell carcinoma (MCC).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma#918584
- Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma#448258
- Adjuvant Avelumab in Merkel Cell Cancer#148757
- Targeted Therapy and Avelumab in Merkel Cell Carcinoma#325300
- Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer#911124
Record · ID 1140355
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive